DNAJC5 and hepatitis A virus infection: Importantly, the outcome of a clinical trial demonstrated that the hybrid RTS,S vaccine achieved higher anti-CSP and anti-HBsAgS antibody responses in children previously vaccinated with the hepatitis B vaccine compared to children in the absence of a hepatitis B vaccination history [46].